Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Cardiovascular Research|October 6, 2025
Sympathovagal crosstalk: Y2-receptor blockade enhances vagal effects which in turn reduce NPY levels via muscarinic receptor activationNeil R Jani, Valerie Y H van Weperen, Thamali Ayagama, et al.
Journal of Cardiovascular Electrophysiology|March 20, 2014
Periprocedural stroke risk in patients undergoing catheter ablation for atrial fibrillation on uninterrupted warfarinStephen P Page, Neil Herring, Ross J Hunter, et al.
Cardiovascular Research|January 14, 2012
Regulation of β-adrenergic control of heart rate by GTP-cyclohydrolase 1 (GCH1) and tetrahydrobiopterinDavid Adlam, Neil Herring, Gillian Douglas, et al.
ESC Heart Failure|April 22, 2024
The effect of sodium-glucose co-transporter 2 inhibitors on outcomes after cardiac resynchronization therapyJonathan J H Bray, Marco Coronelli, Sam G C Scott, et al.
Circulation|May 18, 2023
Retained Metabolic Flexibility of the Failing Human HeartWilliam D Watson, Peregrine G Green, Andrew J M Lewis, et al.
Journal of Cardiovascular Electrophysiology|December 30, 2021
An active fixation quadripolar left ventricular lead for cardiac resynchronization therapy with reduced postoperative complication ratesCalum Robertson, Owen Duffey, Pok-Tin Tang, et al.
Nature Cardiovascular Research|January 3, 2025
Cardiac conduction system regeneration prevents arrhythmias after myocardial infarctionJudy R Sayers, Hector Martinez-Navarro, Xin Sun, et al.
European Heart Journal|March 13, 2019
Neuropeptide-Y causes coronary microvascular constriction and is associated with reduced ejection fraction following ST-elevation myocardial infarctionNeil Herring, Nidi Tapoulal, Manish Kalla, et al.
Journal of Atrial Fibrillation|May 13, 2017
The Prevalence of Low Left Atrial Appendage Emptying Velocity and Thrombus in Patients Undergoing Catheter Ablation for Atrial Fibrillation on Uninterrupted Peri-procedural Warfarin TherapyNeil Herring, Stephen P Page, Mohammed Ahmed, et al.
European Heart Journal|December 14, 2019
The cardiac sympathetic co-transmitter neuropeptide Y is pro-arrhythmic following ST-elevation myocardial infarction despite beta-blockadeManish Kalla, Guoliang Hao, Nidi Tapoulal, et al.
Pageof 8